ResearchMoz

Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

GlobalData
Published Date » 2012-10-08
No. Of Pages » 89
     
  Vertebral Augmentation and Vertebroplasty Devices Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018  
   
   
 GlobalDatas new report, Vertebral Augmentation and Vertebroplasty Devices Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 provides key data, information and analysis on the global vertebral augmentation and vertebroplasty devices market. The report provides market landscape, competitive landscape and market trends information on the vertebral augmentation and vertebroplasty devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. ...
Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 7

2 Introduction 8
2.1 GlobalData Report Guidance 8

3 Vertebral Compression Fractures - Overview 9
3.1 Epidemiology 9
3.2 Acute and Chronic Symptoms 10
3.3 Treatment Options for VCF 11
3.3.1 Benefits of Vertebral Augmentation over Vertebroplasty 13
3.3.2 Potential Complications 13
3.4 Treatment Flow Model for Vertebral Augmentation and Vertebroplasty Devices 13

4 Vertebral Augmentation and Vertebroplasty Devices: Global Market Characterization 15
4.1 Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Historic, 20042011 15
4.2 Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Forecast, 20112018 16
4.3 Vertebral Augmentation and Vertebroplasty Devices Market, Key Trends 18
4.3.1 Recovery of Kyphoplasty and Vertebroplasty Market from Negative Impact of New England Journal of Medicine Studies 18
4.3.2 Niche Status of Vertebral Augmentation Market with High Growth and Low Competition Provides a Great Opportunity for Orthopedic Device Manufacturers 22
4.3.3 Ongoing Studies Comparing the Effectiveness of Vertebral Augmentation and Vertebroplasty Techniques might decide the Course of Future Industry Growth 23
4.4 Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics 29
4.4.1 Market Drivers 30
4.4.2 Market Restraints 38

5 Vertebral Augmentation and Vertebroplasty Devices Market, Analysis by Country, Revenue ($m), 2004 2018 42
5.1 Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Historic, 20042011 42
5.2 Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Forecast, 20112018 43
5.3 Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Historic, 20042011 45
5.4 Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Forecast, 20112018 46
5.5 Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Historic, 20042011 47
5.6 Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Forecast, 20112018 48
5.7 Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Historic, 20042011 49
5.8 Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Forecast, 20112018 51
5.9 Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Historic, 20042011 52
5.10 Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Forecast, 20112018 53
5.11 Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Historic, 20042011 54
5.12 Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Forecast, 20112018 55
5.13 Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Historic, 20042011 56
5.14 Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Forecast, 20112018 57

6 Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Competitive Assessment 59
6.1 Vertebral Augmentation and Vertebroplasty Devices, Key Market Participants 60
6.1.1 Medtronic Inc. 60
6.1.2 Stryker Corporation 65
6.1.3 CareFusion 67

7 Vertebral Augmentation and Vertebroplasty Devices: Other Marketed Products 70
7.1 Confidence Spinal Cement System, Johnson & Johnson (DePuy/Synthes) 70
7.1.1 Product Description 70
7.2 Shield Kyphoplasty System, Soteira 71
7.2.1 Product Description 71
7.3 Kyphoplasty System, BONESUPPORT 71
7.3.1 Product Description 71
7.4 Acu-Cut Vertebral Augmentation System, Ascendx Spine 71
7.4.1 Product Description 71
7.5 V-MAX Delivery System, Johnson & Johnson (DePuy/Synthes) 72
7.5.1 Product Description 72
7.6 Integrated System for Vertebroplasty, Skeltex 72
7.6.1 Product Description 72
7.7 OsseoFix Spinal Fracture Reduction System, Alphatec Spine 72
7.7.1 Product Description 72

8 Vertebral Augmentation and Vertebroplasty Devices: Key Pipeline Products 73
8.1 Crosstrees Pod, Crosstrees Medical Inc. 73
8.1.1 Product Description 73
8.1.2 Product Status 73
8.2 Kiva VCF System, Benvenue Medical, Inc. 74
8.2.1 Product Description 74
8.2.2 Product Status 74
8.3 OsseoFix Spinal Fracture Reduction System, Alphatec Spine, Inc. 74
8.3.1 Product Description 74
8.3.2 Product Status 74
8.4 VerteLift Implant, SpineAlign Medical, Inc. 74
8.4.1 Product Description 74
8.4.2 Product Status 74
8.5 AVAMAX Vertebroplasty Kits, CareFusion 75
8.5.1 Product Description 75
8.5.2 Product Status 75

9 Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Deals Analysis 76
9.1 List of Venture Financing Deals 77
9.2 List of Debt Offerings 79
9.3 List of Partnership Deals 80
9.4 List of Equity Offerings Deals 80
9.5 Key Deals 80
9.5.1 Ascendx Spine Entered into Co-Marketing Agreement with Anwerina 80
9.5.2 Benvenue Medical Raised $25m Series D Financing 81
9.5.3 Shanghai Kinetic Medical Completed IPO for $60m 81

10 Appendix 82
10.1 Market Definitions 82
10.1.1 Vertebral Augmentation and Vertebroplasty Devices 82
10.2 Acronyms 82
10.3 Sources 83
10.4 Research Methodology 87
10.4.1 Secondary Research 88
10.4.2 Primary Research 88
10.4.3 Models 88
10.4.4 Forecasts 89
10.4.5 Expert Panels 89
10.5 GlobalData Consulting 89
10.6 Contact Us 89
10.7 Disclaimer 89

List of Tables


Table 1: VCF Prevalence in Cancer Patients 10
Table 2: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 20042011 15
Table 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 20112018 17
Table 4: Details of New England Journal of Medicine Studies on Vertebroplasty And Vertebral Augmentation Procedures, August 2009 18
Table 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 20082010 19
Table 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 20082011 21
Table 7: FREE (Fracture Reduction Evaluation), 2009 23
Table 8: FREE (Fracture Reduction Evaluation), 2011 24
Table 9: Cancer Patient Fracture Evaluation or CAF

List of Figures


Figure 1: Vertebral Compression Fracture, Treatment Options 11
Figure 2: Treatment Flow Model: Vertebral Augmentation and Vertebroplasty Devices, Global, 2010 13
Figure 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 20042011 15
Figure 4: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 20112018 16
Figure 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 20082010 19
Figure 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 20082011 21
Figure 7: Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics 29
Figure 8: Vertebral Augmentation Devices Market, Japan, Revenue ($m), Forecast, 20112018 35
Figure 9: Vertebral Augmentation and Vertebroplasty Devices Market, by Country, Europe, Revenue ($m), 2011 39
Figure 10: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 20042011 42
Figure 11: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 20112018 43
Figure 12: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 20042011 45
Figure 13: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 20112018 46
Figure 14: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 20042011 47
Figure 15: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 20112018 48
Figure 16: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 20042011 49
Figure 17: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 20112018 51
Figure 18: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 20042011 52
Figure 19: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 20112018 53
Figure 20: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 20042011 54
Figure 21: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 20112018 55
Figure 22: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 20042011 56
Figure 23: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 20112018 57
Figure 24: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Company Share (%), 2011 59
Figure 25: Medtronic, SWOT Analysis 61
Figure 26: Medtronic, Quarterly Revenue Decline from Core Spine, 2012 63
Figure 27: Stryker, SWOT Analysis 65
Figure 28: CareFusion, SWOT Analysis 68
Figure 29: Vertebral Augmentation and Vertebroplasty Devices Market, Key Strategic Deals Analysis, 20102012 76

Upcoming Reports:

Greece: market of mixtures of fruit and vegetable juices
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the mixtures of fruit and vegetable juices market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the mixtures of fruit and vegetable juices market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same...
Premenstrual Dysphoric Disorder Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Premenstrual dysphoric disorder (PMDD) is a severe condition in which most women develop depression, irritability and tension before menstruation. The U.S. Department of Health and Human Services stated that, premenstrual dysphoric disorder is more severe and serious compared to premenstrual syndrome (PMS). Exact cause for premenstrual dysphoric disorder is unknown however researchers demonstrated that few factors are associated with it that includes depression, vitamin deficiency, changes in hormone related to menstrual cycle, drinking alcohol and eating salty food. Possible signs and...
Flame Retardant Chemicals Market - Global Industry Analysis, Size, Market Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Flame retardant chemicals are halogen, nitrogen and phosphorous containing compounds which are added to plastics and rubber in order to reduce the magnitude of burning and inhibit flames. They are increasingly being used in construction of buildings, textiles, and automobile and electronic parts manufacturing.  These additives do not alter the property of the parent material but delays if not completely stop the burning of the material.  With the growing safety regulations with regards to fire and the extensive use of flammable materials, these chemicals have...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Stem Cells to Lead to Healing of Tendons and Lower the Risk of Retears in Rotator Cuff Operations
Mar 30, 2015  
While conducting a rotator cuff operation when an injection comprising the stem cells of bone marrow is used in a patient, it leads to greater tendon durability and better healing. On an annual basis, the U.S. reports close to 2 million cases of rotator cuff surgery. This surgery basically aims at re-attaching the shoulder tendon with the top part of the bone of the upper arm (also known as...
Discovery of a Genetic Link for Treating Liver Related Anomalies
Mar 30, 2015  
Most of the times, any kind of damage that happens to the liver is an irreversible process. But in almost 25 to 30% alcoholics the only solution for issues such as fibrosis, fat accumulation in the liver, and cirrhosis is liver transplant. Latest research and study indicates that certain types of gene mutations might lead to liver cirrhosis that is irreversible. There is likely to be a...
Antacids May Lead to Greater Risk of Bone Fractures
Mar 30, 2015  
Latest observations and research studies have pointed out that a major chunk of the American population who take to antacids and acidity medicines that are available over the counter are at a high risk of suffering bone fractures and cracks. The latest report from Forsyth discusses that the stomach acid present in the gastrointestinal tract has a very important role to play since it enables...
Scottish Construction Industry Reaches an all-time high in Confidence
Mar 30, 2015  
The new Scottish Construction Monitor is now flashing a record confidence level – plus 29 – up by three points than those observed at the end of 2014.  These positive ratings recorded by the quarter one of 2015 in the construction monitor states that the industry has now been rated as positive confidence for continuously seven financial quarters since Q2 of the year...
New Namibian Ministers Set Focus on NHE’s Mass Housing Project
Mar 30, 2015  
Many new ministers in the Namibian ministerial committee caught in the tumultuous mass housing program are awaiting for the country’s project review panel to beat the project. The project review committee is chaired by country’s President Hage Geingob and includes ministers of the National Planning Commission, urban and rural development, and finance....